Bruce A. Leicher
2017 - Momenta Pharmaceuticals
In 2017, Bruce A. Leicher earned a total compensation of $1.5M as Senior Vice President, General Counsel and Secretary at Momenta Pharmaceuticals, a 5% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $144,200 |
|---|---|
| Option Awards | $498,762 |
| Salary | $450,626 |
| Stock Awards | $405,746 |
| Other | $13,331 |
| Total | $1,512,665 |
Leicher received $498.8K in option awards, accounting for 33% of the total pay in 2017.
Leicher also received $144.2K in non-equity incentive plan, $450.6K in salary, $405.7K in stock awards and $13.3K in other compensation.
Rankings
In 2017, Bruce A. Leicher's compensation ranked 6,947th out of 14,666 executives tracked by ExecPay. In other words, Leicher earned more than 52.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,947 out of 14,666 | 53rd |
Division Manufacturing | 2,574 out of 5,772 | 55th |
Major group Chemicals And Allied Products | 833 out of 2,075 | 60th |
Industry group Drugs | 647 out of 1,731 | 63rd |
Industry Biological Products, Except Diagnostic Substances | 119 out of 313 | 62nd |
Source: SEC filing on April 27, 2018.
Leicher's colleagues
We found five more compensation records of executives who worked with Bruce A. Leicher at Momenta Pharmaceuticals in 2017.
2017
Craig Wheeler
Momenta Pharmaceuticals
Chief Executive Officer
2017
Santiago Arroyo
Momenta Pharmaceuticals
Chief Medical Officer
2017
Matthew Ottmer
Momenta Pharmaceuticals
Chief Operating Officer
2017
Ganesh Kaundinya
Momenta Pharmaceuticals
Chief Operating Officer
2017
Scott Storer
Momenta Pharmaceuticals